Rafael Holdings Inc (RFL)

Currency in USD
1.090
0.000(0.00%)
Real-time Data·
Advertisement
RFL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.0601.090
52 wk Range
0.9903.960
Key Statistics
Prev. Close
1.09
Open
1.075
Day's Range
1.06-1.09
52 wk Range
0.99-3.96
Volume
16.37K
Average Volume (3m)
142.26K
1-Year Change
-14.1732%
Book Value / Share
1.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RFL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has fared poorly over the last month

Rafael Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
29/10/2026
EPS / Forecast
-0.18 / --
Revenue / Forecast
244K / --
EPS Revisions
Last 90 days

Rafael (RFL) Income Statement & Profits

Compare RFL to Peers and Sector

Metrics to compare
RFL
Peers
Sector
Relationship
P/E Ratio
−1.9x2.4x−0.2x
PEG Ratio
−0.040.010.00
Price/Book
0.8x0.5x2.6x
Price / LTM Sales
64.2x5.2x2.8x
Upside (Analyst Target)
-83.4%60.5%
Fair Value Upside
Unlock14.6%7.8%Unlock

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C (NPC), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate. The company is also involved in developing Promitil, a pegylated liposomal mitomycin-C lipidic prodrug which is designed molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form. In addition, it develops surgical and procedural devices, including orthopedic arthroscopy instrument for carpal and cubital tunnel syndrome. Further, the company provides technological solutions specifically engineered for increased bioavailability of cannabinoids. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.

Employees
16

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.21M4.24%2.41M
Other Institutional Investors
1.87M3.58%2.03M
Public Companies & Retail Investors
48.10M92.18%52.43M
Total
52.18M100.00%56.88M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard Capital Management, LLC3.01%1,572,5181,714
Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF1.87%975,6371,063

People Also Watch

97.96
FELE
-0.93%
0.2530
NIVF
-13.36%
0.9402
DCX
-5.98%
56.94
JBSS
+0.25%

FAQ

What Is the Rafael (NYSE: RFL) Share Price Today?

The Rafael stock price today is 1.090 USD.

What Stock Exchange Does Rafael (RFL) Trade On?

Rafael is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Rafael?

The stock symbol (also called a 'ticker') for Rafael is "RFL."

What Is the Current Rafael Market Capitalisation?

As of today, Rafael (NYSE: RFL) market cap is 56.880M USD.

What Is Rafael's (RFL) Earnings Per Share (TTM)?

The Rafael EPS is currently -0.58 (Trailing Twelve Months).

Is RFL a Buy or Sell From a Technical Analyst Perspective?

Based on today's Rafael moving averages and other technical indicators, the daily buy/sell signal for RFL stock is Strong Sell.

How Many Times Has Rafael Stock Split?

Rafael has split 0 times. (See the RFL stock split history page for full effective split date and price information.)

How Many Employees Does Rafael Have?

Rafael has 16 employees, based on their latest Companies House report.

What is the current trading status of Rafael (NYSE: RFL)?

As of 12/11/2026, Rafael (RFL) is trading at a share price of 1.090 USD, with a previous close of 1.090 USD. The stock has fluctuated within a day range of 1.060 USD to 1.090 USD, while its 52-week range spans from 0.990 USD to 3.960 USD.

What Is the RFL After Hours Price?

RFL's last after hours stock price is 1.090 USD, the stock has decreased by -0.005, or -0.460%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.